The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation

Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare. Treatment for liver metastases has largely been surgical resection, but this is feasible in only app...

Full description

Bibliographic Details
Main Authors: Emma Loveman, Jeremy Jones, Andrew J Clegg, Joanna Picot, Jillian L Colquitt, Diana Mendes, David J Breen, Emily Moore, Steve George, Graeme Poston, David Cunningham, Theo Ruers, John Primrose
Format: Article
Language:English
Published: NIHR Journals Library 2014-01-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/hta18070